By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNA2.0 on Monday announced a deal with Cosmo Bio to distribute DNA2.0's complete line of bioengineering products.

Financial and other terms of the deal were not disclosed.

Customers can access DNA2.0's products directly, but the deal with Cosmo Bio provides customers in Japan added flexibility and time savings, as well as service and support, DNA2.0 said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times reports that as China invests in science, it also is dealing with research fraud.

In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.

The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.

Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.